The Residual Risk Reduction Initiative - Prof. Alberto J. Lorenzatti

Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
Yes No

Prof. Alberto J. Lorenzatti

Cordoba Hospital
Cordoba, Argentina

Brief Curriculum Vitae

Dr. Alberto J. Lorenzatti is the Chief of Cardiology at the Cordoba Hospital, Córdoba, Argentina.

He also is Co-Director at the DAMIC Medical Institute / Rusculleda Foundation for Research, Teaching and Patient Care (Head of the Clinical Research network with more than 30 research sites in Argentina).

He was trained for metabolic kinetic studies using stable isotopes and mass spectrometry in MIT (Cambridge, MA) and has used this technic and modeling for the lipoprotein turnover measurement. He has developed a translational research on human dyslipidemia and his group was strongly involved in the identification of the first familial hypercholesterolemia with a gain of function PCSK9 mutation and the related dysfunctions. He has published more than 200 peer review original articles or reviews.

University degrees

Medical Doctor, National Córdoba University, School of Medicine, 1980.
Specialist in Cardiology, National Córdoba University, 1988
Certified Clinical Lipidologist, Argentine Lipid Society, 2014
Certified Medical Expert in Clinical Research and Pharmacology, Cordoba Province Medical Council, 2016

Academic background

Invited Professor of Internal Medicine, Cordoba National University, Argentina (current),
Teacher of Postgraduate Training in Cardiology, Córdoba National University, Córdoba Hospital (current).

President of the Argentine Federation of Cardiology (FAC)2020
Current Chair of the Americas Federation from the International Atherosclerosis Society (IAS)
Co-Founder and Ex President of the Argentine Lipids Society (2003-2005)
Member of the Board of Directors of the International Society of Cardiovascular Pharmacotherapy (ISCP)
Dr Lorenzatti is widely involved in clinical research and has served as a Country Lead and a Steering Committee member of many pivotal studies in cardiovascular disease (Jupiter, Cantos, Fourier, Prominent, and SOUL among many others).

Publications

More than 500 Abstracts, Publications and Presentations at National and International levels